Hurd Jonathan Scott 4
4 · INTELLIGENT BIO SOLUTIONS INC. · Filed Mar 20, 2026
Research Summary
AI-generated summary of this filing
Intelligent Bio Solutions (INBS) Director Jonathan Hurd Receives 5,000 Shares
What Happened Jonathan Scott Hurd, a director of Intelligent Bio Solutions Inc. (INBS), was granted 5,000 restricted shares of common stock on March 18, 2026. The award was reported on a Form 4 as an A (award/grant) transaction at a grant price of $0.00 (total reported value $0). This is a compensation award (not an open‑market purchase or sale).
Key Details
- Transaction date: March 18, 2026; Form 4 filed March 20, 2026 (filed within two business days of the transaction).
- Security: Common stock; 5,000 restricted shares granted at $0.00 per share.
- Vesting: Time‑based vesting after 12 months; shares are subject to forfeiture until vested (per footnote).
- Shares owned after transaction: Not specified in the provided filing.
- Footnotes: (1) All amounts are presented post a 1‑for‑10 reverse split effected Dec 15, 2025. (2) Grant made under the Intelligent Bio Solutions Inc. 2019 Long Term Incentive Plan; subject to time‑based vesting and forfeiture.
Context Restricted share awards like this are a form of equity compensation for directors and generally reflect company pay practices rather than an immediate trading signal. The $0 grant price indicates these were awarded shares, not a purchase; they only become freely owned if and when vested according to the plan terms.
Insider Transaction Report
- Award
Common Stock
[F2][F1]2026-03-18+5,000→ 5,006 total
Footnotes (2)
- [F1]On December 15, 2025, Intelligent Bio Solutions Inc. (the "Issuer") effected a 1-for-10 reverse stock split of the Issuer's common stock ("Common Stock"). The reverse stock split effected in December 2025, and prior reverse stock splits effected by the Issuer, resulted in a reduction in the number of shares held by the reporting person and proportional adjustments to the outstanding equity awards held by the reporting person. Accordingly, all amounts in this Form 4 are presented on a post-reverse split basis.
- [F2]On March 18, 2026, the Issuer granted the reporting person 5,000 restricted shares of Common Stock under the Intelligent Bio Solutions Inc. 2019 Long Term Incentive Plan. The awarded shares are subject to time-based vesting after 12 months and are subject to forfeiture until vested.